NeuroMetrix Inc. (NURO)
NeuroMetrix Statistics
Share Statistics
NeuroMetrix has 2.06M shares outstanding. The number of shares has increased by 2.4% in one year.
| Shares Outstanding | 2.06M |
| Shares Change (YoY) | 2.4% |
| Shares Change (QoQ) | 0.83% |
| Owned by Institutions (%) | 4.05% |
| Shares Floating | 1.53M |
| Failed to Deliver (FTD) Shares | 275 |
| FTD / Avg. Volume | 2.64% |
Short Selling Information
The latest short interest is 649, so 0.03% of the outstanding shares have been sold short.
| Short Interest | 649 |
| Short % of Shares Out | 0.03% |
| Short % of Float | 0.03% |
| Short Ratio (days to cover) | 1 |
Valuation Ratios
The PE ratio is -1 and the forward PE ratio is null. NeuroMetrix's PEG ratio is 0.03.
| PE Ratio | -1 |
| Forward PE | n/a |
| PS Ratio | 2.58 |
| Forward PS | 0.3 |
| PB Ratio | 0.55 |
| P/FCF Ratio | -1.1 |
| PEG Ratio | 0.03 |
Enterprise Valuation
Currently the Enterprise Value (EV) is not available for NeuroMetrix.
| EV / Sales | n/a |
| EV / EBITDA | n/a |
| EV / EBIT | n/a |
| EV / FCF | n/a |
Financial Position
The company has a current ratio of 14.83, with a Debt / Equity ratio of 0.01.
| Current Ratio | 14.83 |
| Quick Ratio | 13.5 |
| Debt / Equity | 0.01 |
| Debt / EBITDA | -0.01 |
| Debt / FCF | -0.02 |
| Interest Coverage | 0 |
Financial Efficiency
Return on Equity is n/a and Return on Invested Capital is n/a.
| Return on Equity | n/a |
| Return on Assets | n/a |
| Return on Invested Capital | n/a |
| Revenue Per Employee | $233.3K |
| Profits Per Employee | $-600.47K |
| Employee Count | 13 |
| Asset Turnover | 0.2 |
| Inventory Turnover | 1 |
Taxes
| Income Tax | 0 |
| Effective Tax Rate | 0% |
Stock Price Statistics
The stock price has increased by 21.1% in the last 52 weeks. The beta is 1.83, so NeuroMetrix's price volatility has been higher than the market average.
| Beta | 1.83 |
| 52-Week Price Change | 21.1% |
| 50-Day Moving Average | 4.4 |
| 200-Day Moving Average | 4.02 |
| Relative Strength Index (RSI) | 52.26 |
| Average Volume (20 Days) | 10.44K |
Income Statement
In the last 12 months, NeuroMetrix had revenue of 3.03M and earned -7.81M in profits. Earnings per share was -3.96.
| Revenue | 3.03M |
| Gross Profit | 1.68M |
| Operating Income | -8.78M |
| Net Income | -7.81M |
| EBITDA | -8.78M |
| EBIT | -8.78M |
| Earnings Per Share (EPS) | -3.96 |
Balance Sheet
The company has 1.43M in cash and 107.35K in debt, giving a net cash position of 1.32M.
| Cash & Cash Equivalents | 1.43M |
| Total Debt | 107.35K |
| Net Cash | 1.32M |
| Retained Earnings | -217.92M |
| Total Assets | 15.32M |
| Working Capital | 14M |
Cash Flow
In the last 12 months, operating cash flow was -7.13M and capital expenditures 0, giving a free cash flow of -7.13M.
| Operating Cash Flow | -7.13M |
| Capital Expenditures | 0 |
| Free Cash Flow | -7.13M |
| FCF Per Share | -3.62 |
Margins
Gross margin is 55.38%, with operating and profit margins of -289.57% and -257.38%.
| Gross Margin | 55.38% |
| Operating Margin | -289.57% |
| Pretax Margin | -257.38% |
| Profit Margin | -257.38% |
| EBITDA Margin | -289.57% |
| EBIT Margin | -289.57% |
| FCF Margin | -235.04% |
Dividends & Yields
NURO does not appear to pay any dividends at this time.
| Dividend Per Share | n/a |
| Dividend Yield | n/a |
| Dividend Growth (YoY) | n/a |
| Payout Ratio | n/a |
| Earnings Yield | n/a |
| FCF Yield | n/a |
Analyst Forecast
Currently there are no analyst rating for NURO.
| Price Target | n/a |
| Price Target Difference | n/a |
| Analyst Consensus | n/a |
| Analyst Count | n/a |
Stock Splits
The last stock split was on Nov 22, 2023. It was a backward split with a ratio of 1:8.
| Last Split Date | Nov 22, 2023 |
| Split Type | backward |
| Split Ratio | 1:8 |
Scores
| Altman Z-Score | -15.12 |
| Piotroski F-Score | 1 |